MedTrace Logo

Metal Stents (Moving Cell Stent) for Inoperable Tumors of the Bile Duct Tract

NCT03788655 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2018-12-27

No results posted yet for this study

Summary

In this feasibility study (non-randomized), the applicability of a new "moving cell" biliary stents (by HILZO) in Klatskin tumors (bile duct obstruction) will be investigated.

The HILZO Moving-Cell Stent to be examined here is a non-coated metal stent with a novelty. The meshes have a diameter of 4 mm, which is rather small compared to most other stents. This significantly increases the radial force and thus the stability of the stent. Furthermore, ingrowth by tumors in the stent is difficult. The special feature is that the individual meshes can easily be stretched to 10 mm without changing the stability of the stent. This allows a second stent to pass through the first to another segment of liver.

Conditions

Sponsors & Collaborators

  • Klinikum Stadt Hanau

    collaborator OTHER

  • Johannes Vermehren

    lead OTHER

Principal Investigators

  • Mireen Friedrich-Rust, Prof. · University Clinic Frankfurt am Main

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-31
Primary Completion
2020-12-31
Completion
2021-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03788655 on ClinicalTrials.gov